Variable domain structure of κIV human light chain Len:: High homology to the murine light chain McPC603

被引:34
作者
Huang, DB
Chang, CH
Ainsworth, C
Johnson, G
Solomon, A
Stevens, FJ
Schiffer, M
机构
[1] Argonne Natl Lab, Ctr Mechanist Biol & Biotechnol, Argonne, IL 60439 USA
[2] Univ Tennessee, Med Ctr, Grad Sch Med, Dept Med,Human Immunol & Canc Program, Knoxville, TN 37920 USA
关键词
immunoglobulin; humanization; amyloid; protein stability; x-ray diffraction;
D O I
10.1016/S0161-5890(98)00002-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antibody light chains of the kappa subgroup are the predominant light chain component in human immune responses and are used almost exclusively in the antibody repertoire of mice. Human kappa light chains comprise four subgroups. To date, all crystallographic studies of human kappa light chains were carried out on proteins of the kappa I subgroup. The light chain produced by multiple myeloma patient Len, was of the kappa IV subgroup, it differed by only one residue from the germ-line gene encoded protein. The variable domain fragment of the light chain was crystallized from ammonium sulfate in space group C222(1). The crystal structure was determined by molecular replacement and refined at 1.95 Angstrom resolution to an R-factor of 0.15. Protein Len has six additional residues in its CDR1 segment compared to the kappa I proteins previously characterized. The kappa IV variable domain, Len, differs in only 23 of 113 residues from murine kappa light chain McPC603. The RMS deviation upon superimposing their alpha-carbons was 0.69 Angstrom. The CDRI segment of the human and murine variable domains have the same length and conformation although their amino acid sequences differ in 5 out of 17 residues. Structural features were identified that could account for the significantly higher stability of the human kappa IV protein relative to its murine counterpart. This human kappa IV light chain structure is the closest human homolog to a murine light chain and can be expected to facilitate detailed structural comparisons necessary for effective humanization of murine antibodies. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1291 / 1301
页数:11
相关论文
共 49 条
  • [1] Bellotti V, 1996, NEPHROL DIAL TRANSPL, V11, P1708
  • [2] SLOW-COOLING PROTOCOLS FOR CRYSTALLOGRAPHIC REFINEMENT BY SIMULATED ANNEALING
    BRUNGER, AT
    KRUKOWSKI, A
    ERICKSON, JW
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 : 585 - 593
  • [3] Free R value: Cross-validation in crystallography
    Brunger, AT
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 : 366 - 396
  • [4] BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
  • [5] CLAFLIN JL, 1987, J IMMUNOL, V138, P3060
  • [6] HUMANIZED ANTIBODIES FOR THERAPY
    CO, MS
    QUEEN, C
    [J]. NATURE, 1991, 351 (6326) : 501 - 502
  • [7] CRYSTAL AND MOLECULAR-STRUCTURE OF DIMER OF VARIABLE DOMAINS OF BENCE-JONES PROTEIN ROY
    COLMAN, PM
    SCHRAMM, HJ
    GUSS, JM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1977, 116 (01) : 73 - 79
  • [8] 3-DIMENSIONAL STRUCTURE OF A COMPLEX OF ANTIBODY WITH INFLUENZA-VIRUS NEURAMINIDASE
    COLMAN, PM
    LAVER, WG
    VARGHESE, JN
    BAKER, AT
    TULLOCH, PA
    AIR, GM
    WEBSTER, RG
    [J]. NATURE, 1987, 326 (6111) : 358 - 363
  • [9] SIDE-CHAIN ENTROPY OPPOSES ALPHA-HELIX FORMATION BUT RATIONALIZES EXPERIMENTALLY DETERMINED HELIX-FORMING PROPENSITIES
    CREAMER, TP
    ROSE, GD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) : 5937 - 5941
  • [10] OVERREPRESENTATION OF THE V-KAPPA(IV) SUBGROUP IN LIGHT-CHAIN DEPOSITION DISEASE
    DENOROY, L
    DERET, S
    AUCOUTURIER, P
    [J]. IMMUNOLOGY LETTERS, 1994, 42 (1-2) : 63 - 66